Evidence map›Paper›PMID 36305644›Full record

ReviewBiochemical Society transactions2022

The role of UV-DDB in processing 8-oxoguanine during base excision repair.

Ashna Nagpal, Sripriya Raja, Bennett Van Houten

Open access · hybridAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ashna NagpalUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, U.S.A.
Sripriya RajaUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, U.S.A.
Bennett Van HoutenUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, U.S.A.ORCID 0000-0002-4009-2478
University of Pittsburgh · US

Funding

Watching cooperative interactions between base and nucleotide excision repair proteinsR35ES031638 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bennett Van Houten · 2020 to 2026
$6.2M
NIEHS NIH HHS R35 ES031638
6 · The paper itself

Abstract

Recent data from our laboratory has shown that the nucleotide excision repair (NER) proteins UV-damaged DNA-binding protein (UV-DDB), xeroderma pigmentosum group C (XPC), and xeroderma pigmentosum group A (XPA) play important roles in the processing of 8-oxoG. This review first discusses biochemical studies demonstrating how UV-DDB stimulates human 8-oxoG glycosylase (OGG1), MUTYH, and apurinic/apyrimidinic (AP) endonuclease (APE1) to increase their turnover at damage sites. We further discuss our single-molecule studies showing that UV-DDB associates with these proteins at abasic moieties on DNA damage arrays. Data from cell experiments are then described showing that UV-DDB interacts with OGG1 at sites of 8-oxoG. Finally, since many glycosylases are inhibited from working on damage in the context of chromatin, we present a working model of how UV-DDB may be the first responder to alter the structure of damage containing-nucleosomes to allow access by base excision repair (BER) enzymes.

Indexed as

Xeroderma PigmentosumDNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsDNA DamageDNA RepairGuanineHumans8-hydroxyguanineDNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsGuanine8-oxoguaninebase excision repairnucleotide excision repairOGG1UV-DDB

Identifiers

PMID36305644
PMCPMC9704513
OpenAlexW4307896651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.